
Nilofabicin
CAS No. 934628-27-0
Nilofabicin( CG-400549 | CG 400549 | CG400549 | CG-0549 | CG 0549 | CG0549 | )
Catalog No. M27115 CAS No. 934628-27-0
Nilofabicin is a potent inhibitor of enoyl-(acyl-carrier-protein) reductase fall(FabI) and can be used in studies about the treatment of complicated acute.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 50 | Get Quote |
![]() ![]() |
10MG | 72 | Get Quote |
![]() ![]() |
25MG | 120 | Get Quote |
![]() ![]() |
50MG | 177 | Get Quote |
![]() ![]() |
100MG | 295 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameNilofabicin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNilofabicin is a potent inhibitor of enoyl-(acyl-carrier-protein) reductase fall(FabI) and can be used in studies about the treatment of complicated acute.
-
DescriptionNilofabicin is a potent inhibitor of enoyl-(acyl-carrier-protein) reductase fall(FabI) and can be used in studies about the treatment of complicated acute. (In Vitro):Nilofabicin had an MIC90 of 0.5 μg/ml for Staphylococcus aureus strains and was more potent than either linezolid or vancomycin. Among 203 strains of Staphylococcus aureus, the MICs of Nilofabicin were 0.06 to 1.0 μg/ml, with MIC(50) and MIC(90) values of 0.25 μg/ml each. All strains were susceptible to linezolid and quinupristin-dalfopristin (MICs, 0.25 to 2.0 μg/ml).
-
In Vitro——
-
In Vivo——
-
SynonymsCG-400549 | CG 400549 | CG400549 | CG-0549 | CG 0549 | CG0549 |
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorProstacyclin receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number934628-27-0
-
Formula Weight340.44
-
Molecular FormulaC19H20N2O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (293.74 mM)
-
SMILESCc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bexis S, et, al. Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat. Eur J Pharmacol. 2008 Aug 20;590(1-3):322-6.
molnova catalog



related products
-
Morinidazole
Morinidazole shows antibacterial activity and can be used in studies about bacterial infections research such as appendicitis and pelvic inflammatory disease caused by anaerobic bacteria.
-
N-Acetyl-D-mannosami...
N-Acetylmannosamine is a drug potentially for the treatment of hereditary inclusion body myopathy.
-
(3R,4R)-A2-32-01
(3R,4R)-A2-32-01 is the (R,R)-enantiomer of A2-32-01 and has potential antibacterial activity.